Evidence map›Paper›PMID 39539562›Full record

ArticleBJUI compass2024

Understanding the long-term impact of the COVID-19 pandemic on non-muscle-invasive bladder cancer outcomes: 12-Month follow-up data from the international, prospective COVIDSurg Cancer study.

Cameron E Alexander, Arjun Nathan, Alexander Light, Chuanyu Gao, Vinson Chan, Sinan Khadhouri, Kevin Gallagher, Kevin G Byrnes, Michael Walters, Terry Hughes and 15 more

Erratum issuedAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in BJUI compass, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Erratum.BJUI compass · 2024
    Article
  3. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

25 authors.

Cameron E AlexanderLuton and Dunstable University Hospital Luton UK.ORCID https://orcid.org/0000-0002-9550-6973
Arjun NathanBritish Urology Researchers in Surgical Training (BURST) London UK.ORCID https://orcid.org/0000-0002-8572-2832
Alexander LightBritish Urology Researchers in Surgical Training (BURST) London UK.
Chuanyu GaoBritish Urology Researchers in Surgical Training (BURST) London UK.ORCID https://orcid.org/0000-0002-9824-6468
Vinson ChanBritish Urology Researchers in Surgical Training (BURST) London UK.ORCID https://orcid.org/0000-0002-6108-9315
Sinan KhadhouriBritish Urology Researchers in Surgical Training (BURST) London UK.ORCID https://orcid.org/0000-0002-1836-8992
Kevin GallagherBritish Urology Researchers in Surgical Training (BURST) London UK.ORCID https://orcid.org/0000-0001-5485-5336
Kevin G ByrnesBritish Urology Researchers in Surgical Training (BURST) London UK.
Michael WaltersBirmingham Centre for Observational and Prospective Studies University of Birmingham Birmingham UK.
Terry HughesBirmingham Centre for Observational and Prospective Studies University of Birmingham Birmingham UK.
Rita PerryBirmingham Centre for Observational and Prospective Studies University of Birmingham Birmingham UK.
Kelvin OkothBirmingham Centre for Observational and Prospective Studies University of Birmingham Birmingham UK.
Laura MagillBirmingham Centre for Observational and Prospective Studies University of Birmingham Birmingham UK.
Thomas PinkneyBirmingham Centre for Observational and Prospective Studies University of Birmingham Birmingham UK.
Joseph B JohnUniversity of Exeter Medical School Exeter UK.
John S McGrathUniversity of Exeter Medical School Exeter UK.ORCID https://orcid.org/0000-0001-9416-9912
Alexandra ColquhounCambridge University Hospitals NHS Foundation Trust Cambridge UK.
Yuhao ZhangStepping Hill Hospital Stockport NHS Foundation Trust Stockport UK.
James BlackmurInstitute of Genetics and Cancer University of Edinburgh Edinburgh UK.
Eric EtchillJohns Hopkins Hospital Baltimore Maryland USA.
Stanley TangDivision of Surgery and Interventional Sciences University College London London UK.
Damián García EscuderoHospital General Reina Sofía Murcia Spain.
Grant StewartRoyal Devon University Healthcare NHS Foundation Trust Exeter UK.ORCID https://orcid.org/0000-0003-3188-9140
Veeru KasivisvanathanBritish Urology Researchers in Surgical Training (BURST) London UK.ORCID https://orcid.org/0000-0002-0832-382X
COVIDSurg Collaborative

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: The objective of this study was to report the 12-month oncological outcomes for patients with non-muscle-invasive bladder cancer (NMIBC) within the prospective, international COVIDSurg Cancer study. Patients and methods: Eligible patients were aged ≥18 years and scheduled for elective surgical management of NMIBC with curative intent (transurethral resection of bladder tumour [TURBT] or bladder biopsy) from 21 January to 14 April 2020. The primary outcome was disease recurrence within 12 months of previous elective TURBT/bladder biopsy. Secondary outcomes included disease progression within 12 months of previous elective TURBT/bladder biopsy, site-declared delay to surgery from diagnosis as a consequence of COVID-19 and deviation in standard care due to COVID-19. Comparisons were made to cohorts from the pre-pandemic era. Results: Bladder cancer accounted for 2.2% ( Conclusions: This prospective study indicates that there were widespread deviations in usual care for NMIBC during the pandemic and that 12-month oncological outcomes appear to be impaired compared to published pre-pandemic outcomes.

Indexed as

bladder cancerCOVID‐19delaynon‐muscle invasivepandemicsurgery

Identifiers

PMID39539562
PMCPMC11557269

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.